School of Optometry & Vision Sciences
Cardiff, United Kingdom
NCT Number: NCT01190397
The eyelid warming device is designed to relieve the symptoms of dysfunction of the glands in the eyelids
Phase I, prospective, comparative study, investigator masked , monocentric
Objectives are To assess and compare the warming and moisture of Blephasteam® device versus the warming and moisture of warm and moist compresses.
To assess and compare safety on the ocular surface after 10 minutes of Blephasteam® application versus after 10 minutes of warm and moist compresses application
Looking for future studies?
Notify Me4 year and older
All sexes
Interventional
Phase 1
Cardiff, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The temperature in the chamber of the goggles for Blephasteam device, or between the lid and the compresses for the moist and warm compress, will be evaluated in 10 consecutive measurements over a period of 10 minutes with a micro sensor at the lower lid margin of one randomly selected eye of 10 randomly selected subjects
The humidity in the chamber of the goggles for Blephasteam device, or between the lid and the compresses for the moist and warm compress, will be evaluated in 10 consecutive measurements over a period of 10 minutes with a micro sensor at the lower lid margin of one randomly selected eye of 10 randomly selected subjects.
Laboratoires Thea
Industry
Phase I, Prospective, Comparative Study, Investigator Masked , Monocentric Measuring Warming Efficiency and Safety of Blephasteam® Versus Warm Compresses in Eyelid Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04235803
Blepharoptosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
San Francisco, California, United States
View Trial DetailsNCT06279143
BCC, BCC - Basal Cell Carcinoma
Vejle, Region of Southern Danmark, Denmark
View Trial DetailsNCT04149210
Eye Diseases, Eyelid Diseases
Addis Ababa, Ethiopia
View Trial DetailsNCT04898933
Eye Diseases, Eyelid Diseases
Abu Dhabi, United Arab Emirates
View Trial Details